We could observe in a recent study beta2-AR-AAB to inhibit LPS-induced tumor necrosis factor (TNF) release, and their inhibitory function was impaired in ME/CFS with higher beta2-AR-AAB (36). This evidence concerns the gene TNF and myalgic encephalomeyelitis/chronic fatigue syndrome.